Related Experiment Video
Updated: Jun 29, 2025

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Reply: Evaluation of the Inclisiran Safety in High-Risk Populations
R Scott Wright1, Lawrence A Leiter2, Anastasia Lesogor3
1Mayo Clinic, Rochester, Minnesota, USA.
No abstract available in PubMed .
More Related Videos
06:19Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
Published on: May 31, 2024
05:56Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases
Published on: January 9, 2019
Related Concept Videos
Dipeptidyl Peptidase 4 Inhibitors
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Clinical Trials
There are four phases in a clinical trial. A phase one...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents